Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses.
Nolting S, Semig G, Friedrich HK, Dietz M, Reckers-Czaschka R, Bergstraesser M, Zaug M.
Nolting S, et al.
Clin Exp Dermatol. 1992 Sep;17 Suppl 1:56-60. doi: 10.1111/j.1365-2230.1992.tb00280.x.
Clin Exp Dermatol. 1992.
PMID: 1458667
Clinical Trial.
Therapy with 0.125, 0.25, 0.5% amorolfine cream or 1% bifonazole cream was randomly allocated to patients. The cream was applied once daily for 4 weeks on average. ...One to three weeks after ending therapy, the percentage of patients with negative cultures were as follows …
Therapy with 0.125, 0.25, 0.5% amorolfine cream or 1% bifonazole cream was randomly allocated to patients. The cream was applied once …